Sean F. Scanlan Treace Medical Concepts, Inc. (TMCI) insider trading activity
Sean F. Scanlan is Chief Innovation Officer of TREACE MEDICAL CONCEPTS, INC.. Currently has a direct ownership of 250,074 shares of TMCI, which is worth approximately $2.07 Million. The most recent transaction as insider was on Jan 11, 2022, when has been sold 8,838 shares (Common Stock) at a price of $1.31 per share, resulting in proceeds of $11,578. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
250K
15.6%
3M change
677.01%
12M change
Total Value Held
$2.07 Million
Sean F. Scanlan Transaction History
SFS
Sean F. Scanlan
Chief Innovation Officer
Ponte Vedra, FL